StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3011% below fair value
$0.94−0.07 (-6.71%)

Close on Nov 20, 2026Market cap $94.41MP/E –Yield –

Stereotaxis net income

Net income is the profit left for shareholders after every expense, interest and tax.

Stereotaxis's net income for the twelve months ending Jun 30, 2026 was -$22.32M. For fiscal 2025 it was -$21.64M. The highest annual figure on record is $116.76K in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.64M–
FY2024Dec 31, 2024-$24.05M–
FY2023Dec 31, 2023-$20.71M–
FY2022Dec 31, 2022-$18.29M–
FY2021Dec 31, 2021-$10.72M–
FY2020Dec 31, 2020-$6.65M–
FY2019Dec 31, 2019-$4.59M-4032.4%
FY2018Dec 31, 2018$116.76K–
FY2017Dec 31, 2017-$5.89M–
FY2016Dec 31, 2016-$5.29M–
FY2015Dec 31, 2015-$7.35M–
FY2014Dec 31, 2014-$5.20M–
FY2013Dec 31, 2013-$68.76M–
FY2012Dec 31, 2012-$9.24M–
FY2011Dec 31, 2011-$32.03M–
FY2010Dec 31, 2010-$19.92M–
FY2009Dec 31, 2009-$27.49M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.47M–
Q1 FY2026Mar 31, 2026-$5.86M–
Q4 FY2025Dec 31, 2025-$5.53M–
Q3 FY2025Sep 30, 2025-$6.46M–
Q2 FY2025Jun 30, 2025-$3.83M–
Q1 FY2025Mar 31, 2025-$5.82M–
Q4 FY2024Dec 31, 2024-$7.52M–
Q3 FY2024Sep 30, 2024-$6.19M–
Q2 FY2024Jun 30, 2024-$5.83M–
Q1 FY2024Mar 31, 2024-$4.51M–
Q4 FY2023Dec 31, 2023-$5.04M–
Q3 FY2023Sep 30, 2023-$5.37M–
Q2 FY2023Jun 30, 2023-$4.96M–
Q1 FY2023Mar 31, 2023-$5.35M–
Q4 FY2022Dec 31, 2022-$4.15M–
Q3 FY2022Sep 30, 2022-$4.92M–
Q2 FY2022Jun 30, 2022-$5.13M–
Q1 FY2022Mar 31, 2022-$4.09M–
Q4 FY2021Dec 31, 2021-$3.36M–
Q3 FY2021Sep 30, 2021-$4.62M–
Q2 FY2021Jun 30, 2021-$1.21M–
Q1 FY2021Mar 31, 2021-$1.53M–
Q4 FY2020Dec 31, 2020-$1.18M–
Q3 FY2020Sep 30, 2020-$1.57M-3695.5%
Q2 FY2020Jun 30, 2020-$1.92M–
Q1 FY2020Mar 31, 2020-$1.97M–
Q4 FY2019Dec 31, 2019-$1.08M–
Q3 FY2019Sep 30, 2019$43.75K–
Q2 FY2019Jun 30, 2019-$1.43M–
Q1 FY2019Mar 31, 2019-$2.12M-247.9%
Q4 FY2018Dec 31, 2018-$569.97K–
Q3 FY2018Sep 30, 2018-$116.30K–
Q2 FY2018Jun 30, 2018-$632.21K–
Q1 FY2018Mar 31, 2018$1.44M+21.9%
Q4 FY2017Dec 31, 2017-$2.55M-146.1%
Q3 FY2017Sep 30, 2017-$4.33M–
Q2 FY2017Jun 30, 2017-$177.30K–
Q1 FY2017Mar 31, 2017$1.18M–
Q4 FY2016Dec 31, 2016$5.53M–
Q3 FY2016Sep 30, 2016-$6.21M–

More Stereotaxis figures

See a number that looks wrong?